GLP-1 medicines and sleep apnoea: the honest picture
Obstructive sleep apnoea, where the airway partly or fully closes during sleep, is common in people carrying extra weight, because extra tissue around the neck narrows the airway. Losing weight is one of the few things that can actually reduce sleep apnoea severity, and a 10 percent drop in body weight can cut the apnoea count by about a quarter to a third. The SURMOUNT-OSA trial of tirzepatide in adults with obesity and moderate-to-severe sleep apnoea found a large drop in the apnoea count compared with placebo, on top of weight loss. Semaglutide has less direct apnoea-count evidence so far, mostly from observational data. The honest line is this: these medicines can help sleep apnoea mainly through weight loss, they are not a replacement for CPAP, and many people still need CPAP even after losing weight.
Unlock the complete article
Register with just your mobile number and OTP. No password and no payment.